Compare ATRC & TRIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATRC | TRIP |
|---|---|---|
| Founded | 2000 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.1B |
| IPO Year | 2005 | 2011 |
| Metric | ATRC | TRIP |
|---|---|---|
| Price | $29.56 | $9.38 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 13 |
| Target Price | ★ $51.17 | $14.88 |
| AVG Volume (30 Days) | 818.3K | ★ 4.1M |
| Earning Date | 05-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 74.74 | ★ 675.00 |
| EPS | N/A | ★ 0.31 |
| Revenue | $201,630,000.00 | ★ $1,556,000,000.00 |
| Revenue This Year | $15.17 | $3.33 |
| Revenue Next Year | $12.42 | $5.12 |
| P/E Ratio | ★ N/A | $31.71 |
| Revenue Growth | ★ 15.40 | N/A |
| 52 Week Low | $28.32 | $9.46 |
| 52 Week High | $43.18 | $20.16 |
| Indicator | ATRC | TRIP |
|---|---|---|
| Relative Strength Index (RSI) | 31.89 | 29.76 |
| Support Level | $28.64 | N/A |
| Resistance Level | $32.85 | $15.37 |
| Average True Range (ATR) | 1.26 | 0.45 |
| MACD | 0.02 | 0.06 |
| Stochastic Oscillator | 21.20 | 7.38 |
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Tripadvisor is the world's leading travel metasearch company. Its platform offers 1 billion reviews and information on several million accommodations, restaurants, experiences, airlines, and cruises. In 2024, 52% of revenue came from the company's core Brand Tripadvisor segment, which includes hotel revenue generated through advertising on its metasearch platform (33% of 2024 sales). Viator, its experiences brand, was 46% of revenue in 2024, and TheFork, its dining brand, represented 10% of sales (about 8% of revenue were intersegment, which are eliminated from consolidated revenue).